PARANEOPLASTIC NEUROLOGICAL SYNDROME

This adverse event was reported 128 times

These drugs are most commonly taken by patients reporting PARANEOPLASTIC NEUROLOGICAL SYNDROME:

# Drug Count
0 ATEZOLIZUMAB 35
1 CARBOPLATIN 32
2 ETOPOSIDE 28
3 PEMBROLIZUMAB 19
4 NIVOLUMAB 13
5 DURVALUMAB 11
6 BEVACIZUMAB 6
7 METHYLPREDNISOLONE 6
8 RITUXIMAB 6
9 CISPLATIN 5
See all common drugs associated with PARANEOPLASTIC NEUROLOGICAL SYNDROME

PARANEOPLASTIC NEUROLOGICAL SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BEVACIZUMAB-MALY 1 0.0050
1 HYALURONATE SODIUM 2 0.0013
2 SENNOSIDES A AND B 2 0.0012
3 BACILLUS CALMETTE-GUERIN 2 0.0011
4 UREA 2 0.0009
5 ATEZOLIZUMAB 35 0.0009
6 DURVALUMAB 11 0.0005
7 AVELUMAB 2 0.0005
8 ETOPOSIDE 28 0.0004
9 PALONOSETRON HYDROCHLORIDE 2 0.0004
See all drugs enriched for association with PARANEOPLASTIC NEUROLOGICAL SYNDROME